Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
Scinai Immunotherapeutics (SCNI) Stock Price & Analysis
279 Followers
SCNI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.43 - $2.27
Previous Close$0.46
Volume5.39K
Average Volume (3M)28.63K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)₪10.93M
Total Debt (Recent Filing)₪23.28M
Price to Earnings (P/E)N/A
Beta1.25
Next Earnings
Apr 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,284,058
10 Day Avg. Volume35,410
30 Day Avg. Volume28,625
Standard Deviation0.28
R-Squared0.22
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.33
Price to Sales (P/S)0.20
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Scinai Immunotherapeutics News
PremiumCompany Announcements
Scinai Immunotherapeutics Advances NanoAb Pipeline
PremiumCompany Announcements
Scinai Targets IL-17 in Psoriasis Drug Development
Ownership Overview
0.00%
Insiders
0.04% Mutual Funds
<0.01% Other Institutional Investors
99.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SCNI FAQ
What was Scinai Immunotherapeutics’s price range in the past 12 months?
Scinai Immunotherapeutics lowest stock price was $0.43 and its highest was $2.27 in the past 12 months.
What is Scinai Immunotherapeutics’s market cap?
Currently, no data Available
When is Scinai Immunotherapeutics’s upcoming earnings report date?
Scinai Immunotherapeutics’s upcoming earnings report date is Apr 30, 2024 which is tomorrow.
How were Scinai Immunotherapeutics’s earnings last quarter?
Scinai Immunotherapeutics released its earnings results on Oct 31, 2023. The company reported $0.002 earnings per share for the quarter, beating the consensus estimate of -$0.94 by $0.942.
Is Scinai Immunotherapeutics overvalued?
According to Wall Street analysts Scinai Immunotherapeutics’s price is currently Overvalued.
Does Scinai Immunotherapeutics pay dividends?
Scinai Immunotherapeutics does not currently pay dividends.
What is Scinai Immunotherapeutics’s EPS estimate?
Scinai Immunotherapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scinai Immunotherapeutics have?
Scinai Immunotherapeutics has 3,651,927 shares outstanding.
What happened to Scinai Immunotherapeutics’s price movement after its last earnings report?
Scinai Immunotherapeutics reported an EPS of $0.002 in its last earnings report, beating expectations of -$0.94. Following the earnings report the stock price went up 3.125%.
Which hedge fund is a major shareholder of Scinai Immunotherapeutics?
Currently, no hedge funds are holding shares in SCNI
---
Scinai Immunotherapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Scinai Immunotherapeutics
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.
---
Technical Analysis
---